The global epilepsy therapeutics market, valued at US$ 10.6 billion in 2021, is projected to reach US$ 14.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 3.5% from 2022 to 2031. Epilepsy therapeutics include anti-epileptic drugs (AEDs), surgical interventions, neuromodulation devices, and emerging therapies like gene therapy,
The global animal healthcare market, valued at US$ 34.5 billion in 2020, is projected to reach US$ 63.2 billion by 2028, expanding at a compound annual growth rate (CAGR) of 7.2% from 2021 to 2028. This market encompasses veterinary pharmaceuticals, vaccines, feed additives, diagnostics, and medical devices for companion animals (e.g., dogs, cats)
The global geriatric medicine market, valued at US$ 672.0 billion in 2018, was projected to expand at a compound annual growth rate (CAGR) of 6.9% from 2019 to 2027, reaching approximately US$ 1,206.7 billion by the end of 2027. Geriatric medicine focuses on healthcare for the elderly, addressing chronic diseases, polypharmacy, and age-related cond
The global drug eluting balloon (DEB) market, valued at US$ 571.1 million in 2022, is projected to reach US$ 1.0 billion by 2031, driven by a compound annual growth rate (CAGR) of 7.1% from 2023 to 2031. Drug eluting balloons, coated with anti-proliferative drugs like paclitaxel, are used in interventional cardiology and peripheral vascular procedu
The global hydrodeoxygenation (HDO) catalysts market, valued at US$ 123.4 million in 2022, is projected to reach US$ 196.4 million by 2031, driven by a compound annual growth rate (CAGR) of 5.3% from 2023 to 2031. HDO catalysts, primarily metal-based (e.g., nickel, molybdenum), are essential for removing oxygen from biomass-derived oils to produce